Tuberous Sclerosis Complex — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — mTOR inhibitor (everolimus)
Everolimus, an mTOR inhibitor, is approved for growing SEGAs in TSC patients not candidates for surgery.
Reference: RCH Melbourne – 2024 – Clinical Practice Guidelines: TSC